Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?

Wu, GZ; Wang, QL; Xu, YK; Li, JY; Zhang, HG; Qi, GH; Xia, QH

Xia, QH (reprint author), Shandong Univ, Shandong Prov Hosp, Dept Urol, Jinan, Shandong, Peoples R China.

CELL DEATH & DISEASE, 2019; 10 ():

Abstract

Growing evidence indicates that clear cell renal cell carcinoma (ccRCC) is a metabolism-related disease. Changes in fatty acid (FA) and cholesterol me......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索